Compare ALEMBIC with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs PFIZER - Comparison Results

ALEMBIC     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PFIZER ALEMBIC/
PFIZER
 
P/E (TTM) x 74.5 48.9 152.3% View Chart
P/BV x 6.4 8.1 79.1% View Chart
Dividend Yield % 0.2 0.4 37.7%  

Financials

 ALEMBIC   PFIZER
EQUITY SHARE DATA
    ALEMBIC
Mar-18
PFIZER
Mar-19
ALEMBIC/
PFIZER
5-Yr Chart
Click to enlarge
High Rs723,840 1.9%   
Low Rs342,080 1.6%   
Sales per share (Unadj.) Rs4.7455.0 1.0%  
Earnings per share (Unadj.) Rs6.193.8 6.5%  
Cash flow per share (Unadj.) Rs6.2109.4 5.7%  
Dividends per share (Unadj.) Rs0.2022.50 0.9%  
Dividend yield (eoy) %0.40.8 49.7%  
Book value per share (Unadj.) Rs40.7658.2 6.2%  
Shares outstanding (eoy) m267.0345.75 583.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.36.5 173.1%   
Avg P/E ratio x8.731.6 27.5%  
P/CF ratio (eoy) x8.527.1 31.3%  
Price / Book Value ratio x1.34.5 29.0%  
Dividend payout %3.324.0 13.7%   
Avg Mkt Cap Rs m14,139135,420 10.4%   
No. of employees `000NA2.6 0.0%   
Total wages/salary Rs m2073,238 6.4%   
Avg. sales/employee Rs ThNM7,911.4-  
Avg. wages/employee Rs ThNM1,230.9-  
Avg. net profit/employee Rs ThNM1,630.7-  
INCOME DATA
Net Sales Rs m1,25520,815 6.0%  
Other income Rs m3701,674 22.1%   
Total revenues Rs m1,62522,489 7.2%   
Gross profit Rs m1115,712 1.9%  
Depreciation Rs m38714 5.3%   
Interest Rs m273 2.3%   
Profit before tax Rs m4426,599 6.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m242,309 1.0%   
Profit after tax Rs m1,6304,291 38.0%  
Gross profit margin %8.927.4 32.3%  
Effective tax rate %5.435.0 15.5%   
Net profit margin %129.820.6 629.9%  
BALANCE SHEET DATA
Current assets Rs m1,86727,167 6.9%   
Current liabilities Rs m5918,917 6.6%   
Net working cap to sales %101.687.7 115.9%  
Current ratio x3.23.0 103.7%  
Inventory Days Days9468 139.0%  
Debtors Days Days7430 244.3%  
Net fixed assets Rs m1,7918,862 20.2%   
Share capital Rs m534458 116.7%   
"Free" reserves Rs m10,32429,656 34.8%   
Net worth Rs m10,85830,113 36.1%   
Long term debt Rs m4125 164.8%   
Total assets Rs m11,59139,400 29.4%  
Interest coverage x260.991.5 285.0%   
Debt to equity ratio x00 457.1%  
Sales to assets ratio x0.10.5 20.5%   
Return on assets %14.111.1 127.1%  
Return on equity %15.014.2 105.4%  
Return on capital %15.222.1 68.6%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263NA-   
Fx inflow Rs m19428 4.5%   
Fx outflow Rs m264786 33.5%   
Net fx Rs m-244-358 68.3%   
CASH FLOW
From Operations Rs m236978 24.1%  
From Investments Rs m-224351 -63.8%  
From Financial Activity Rs m-27-1,099 2.4%  
Net Cashflow Rs m-15231 -6.4%  

Share Holding

Indian Promoters % 64.0 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 0.2 7.5 2.7%  
FIIs % 9.7 4.9 198.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 23.7 110.1%  
Shareholders   54,701 85,207 64.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC With:   DR. REDDYS LAB  IPCA LABS  NATCO PHARMA  TTK HEALTHCARE  SUN PHARMA  

Compare ALEMBIC With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

SGX Nifty Down 34 Points; Indicates Negative Opening for Indian Stock Markets(SGX Nifty)

The SGX Nifty opened on a negative note today. At 8:05 am, it was trading down by 34 points, or 0.2% lower at 14,675 levels.

Related Views on News

PFIZER Announces Quarterly Results (3QFY21); Net Profit Up 1.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, PFIZER has posted a net profit of Rs 1 bn (up 1.6% YoY). Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY21); Net Profit Down 14.8% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, PFIZER has posted a net profit of Rs 1 bn (down 14.8% YoY). Sales on the other hand came in at Rs 6 bn (up 5.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY21); Net Profit Up 10.3% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, PFIZER has posted a net profit of Rs 1 bn (up 10.3% YoY). Sales on the other hand came in at Rs 5 bn (down 5.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

PFIZER Announces Quarterly Results (3QFY20); Net Profit Up 5.4% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, PFIZER has posted a net profit of Rs 1 bn (up 5.4% YoY). Sales on the other hand came in at Rs 5 bn (up 4.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

The Worst Sector in the Market(Fast Profits Daily)

May 11, 2021

The worst sector in the stock market according to the charts.

The Key to Profit from India's EV Revolution(Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC SHARE PRICE


May 12, 2021 (Close)

TRACK ALEMBIC

  • Track your investment in ALEMBIC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC - STRIDES PHARMA SCIENCE COMPARISON

COMPARE ALEMBIC WITH

MARKET STATS